Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 99

1.

Transcriptional recapitulation and subversion of embryonic colon development by mouse colon tumor models and human colon cancer.

Kaiser S, Park YK, Franklin JL, Halberg RB, Yu M, Jessen WJ, Freudenberg J, Chen X, Haigis K, Jegga AG, Kong S, Sakthivel B, Xu H, Reichling T, Azhar M, Boivin GP, Roberts RB, Bissahoyo AC, Gonzales F, Bloom GC, Eschrich S, Carter SL, Aronow JE, Kleimeyer J, Kleimeyer M, Ramaswamy V, Settle SH, Boone B, Levy S, Graff JM, Doetschman T, Groden J, Dove WF, Threadgill DW, Yeatman TJ, Coffey RJ Jr, Aronow BJ.

Genome Biol. 2007;8(7):R131.

2.

SPDEF functions as a colorectal tumor suppressor by inhibiting β-catenin activity.

Noah TK, Lo YH, Price A, Chen G, King E, Washington MK, Aronow BJ, Shroyer NF.

Gastroenterology. 2013 May;144(5):1012-1023.e6. doi: 10.1053/j.gastro.2013.01.043. Epub 2013 Feb 1.

3.

Expression of osteopontin, a target gene of de-regulated Wnt signaling, predicts survival in colon cancer.

Rohde F, Rimkus C, Friederichs J, Rosenberg R, Marthen C, Doll D, Holzmann B, Siewert JR, Janssen KP.

Int J Cancer. 2007 Oct 15;121(8):1717-23.

4.

MicroRNA-93 suppress colorectal cancer development via Wnt/β-catenin pathway downregulating.

Tang Q, Zou Z, Zou C, Zhang Q, Huang R, Guan X, Li Q, Han Z, Wang D, Wei H, Gao X, Wang X.

Tumour Biol. 2015 Mar;36(3):1701-10. doi: 10.1007/s13277-014-2771-6. Epub 2014 Nov 5.

PMID:
25371073
5.

ITF2 prevents activation of the β-catenin-TCF4 complex in colon cancer cells and levels decrease with tumor progression.

Shin HW, Choi H, So D, Kim YI, Cho K, Chung HJ, Lee KH, Chun YS, Cho CH, Kang GH, Kim WH, Park JW.

Gastroenterology. 2014 Aug;147(2):430-442.e8. doi: 10.1053/j.gastro.2014.04.047. Epub 2014 May 15.

PMID:
24846398
6.

Molecular profiling of mouse lung tumors: association with tumor progression, lung development, and human lung adenocarcinomas.

Bonner AE, Lemon WJ, Devereux TR, Lubet RA, You M.

Oncogene. 2004 Feb 5;23(5):1166-76.

PMID:
14647414
7.

Transcriptional profiles of intestinal tumors in Apc(Min) mice are unique from those of embryonic intestine and identify novel gene targets dysregulated in human colorectal tumors.

Reichling T, Goss KH, Carson DJ, Holdcraft RW, Ley-Ebert C, Witte D, Aronow BJ, Groden J.

Cancer Res. 2005 Jan 1;65(1):166-76.

8.

Wnt signaling inhibits Forkhead box O3a-induced transcription and apoptosis through up-regulation of serum- and glucocorticoid-inducible kinase 1.

Dehner M, Hadjihannas M, Weiske J, Huber O, Behrens J.

J Biol Chem. 2008 Jul 11;283(28):19201-10. doi: 10.1074/jbc.M710366200. Epub 2008 May 16.

9.

The myc 3' wnt-responsive element suppresses colonic tumorigenesis.

Konsavage WM Jr, Yochum GS.

Mol Cell Biol. 2014 May;34(9):1659-69. doi: 10.1128/MCB.00969-13. Epub 2014 Feb 24.

10.

Wnt/β-catenin signaling regulates Yes-associated protein (YAP) gene expression in colorectal carcinoma cells.

Konsavage WM Jr, Kyler SL, Rennoll SA, Jin G, Yochum GS.

J Biol Chem. 2012 Apr 6;287(15):11730-9. doi: 10.1074/jbc.M111.327767. Epub 2012 Feb 15.

11.

Cdx2 controls expression of the protocadherin Mucdhl, an inhibitor of growth and β-catenin activity in colon cancer cells.

Hinkel I, Duluc I, Martin E, Guenot D, Freund JN, Gross I.

Gastroenterology. 2012 Apr;142(4):875-885.e3. doi: 10.1053/j.gastro.2011.12.037. Epub 2011 Dec 24.

PMID:
22202456
12.

Reduced level of smoothened suppresses intestinal tumorigenesis by down-regulation of Wnt signaling.

Arimura S, Matsunaga A, Kitamura T, Aoki K, Aoki M, Taketo MM.

Gastroenterology. 2009 Aug;137(2):629-38. doi: 10.1053/j.gastro.2009.04.059. Epub 2009 May 7.

PMID:
19427313
13.

Mouse model of colonic adenoma-carcinoma progression based on somatic Apc inactivation.

Hinoi T, Akyol A, Theisen BK, Ferguson DO, Greenson JK, Williams BO, Cho KR, Fearon ER.

Cancer Res. 2007 Oct 15;67(20):9721-30.

14.

Cables1 is a tumor suppressor gene that regulates intestinal tumor progression in Apc(Min) mice.

Arnason T, Pino MS, Yilmaz O, Kirley SD, Rueda BR, Chung DC, Zukerberg LR.

Cancer Biol Ther. 2013 Jul;14(7):672-8. doi: 10.4161/cbt.25089. Epub 2013 May 31.

15.

A colorectal cancer expression profile that includes transforming growth factor beta inhibitor BAMBI predicts metastatic potential.

Fritzmann J, Morkel M, Besser D, Budczies J, Kosel F, Brembeck FH, Stein U, Fichtner I, Schlag PM, Birchmeier W.

Gastroenterology. 2009 Jul;137(1):165-75. doi: 10.1053/j.gastro.2009.03.041. Epub 2009 Mar 26.

PMID:
19328798
16.

Gene expression profile analysis of mouse colon embryonic development.

Park YK, Franklin JL, Settle SH, Levy SE, Chung E, Jeyakumar LH, Shyr Y, Washington MK, Whitehead RH, Aronow BJ, Coffey RJ.

Genesis. 2005 Jan;41(1):1-12.

PMID:
15645444
17.

Large differences in global transcriptional regulatory programs of normal and tumor colon cells.

Cordero D, Solé X, Crous-Bou M, Sanz-Pamplona R, Paré-Brunet L, Guinó E, Olivares D, Berenguer A, Santos C, Salazar R, Biondo S, Moreno V.

BMC Cancer. 2014 Sep 24;14:708. doi: 10.1186/1471-2407-14-708.

18.

Tumor suppressor DLC-1 induces apoptosis and inhibits the growth and invasion of colon cancer cells through the Wnt/β-catenin signaling pathway.

Wang C, Wang J, Liu H, Fu Z.

Oncol Rep. 2014 May;31(5):2270-8. doi: 10.3892/or.2014.3057. Epub 2014 Mar 5.

PMID:
24604602
19.

Regulation of the tumor suppressor homeogene Cdx2 by HNF4α in intestinal cancer.

Saandi T, Baraille F, Derbal-Wolfrom L, Cattin AL, Benahmed F, Martin E, Cardot P, Duclos B, Ribeiro A, Freund JN, Duluc I.

Oncogene. 2013 Aug 8;32(32):3782-8. doi: 10.1038/onc.2012.401. Epub 2012 Sep 17.

PMID:
22986531
20.

Quantitatively controlling expression of miR-17~92 determines colon tumor progression in a mouse tumor model.

Jiang H, Wang P, Wang Q, Wang B, Mu J, Zhuang X, Zhang L, Yan J, Miller D, Zhang HG.

Am J Pathol. 2014 May;184(5):1355-68. doi: 10.1016/j.ajpath.2014.01.037. Epub 2014 Mar 27.

Items per page

Supplemental Content

Write to the Help Desk